ea0014oc10.2 | Obesity & metabolism | ECE2007
Konopelska Sarah
, Kienitz Tina
, Pirlich Matthias
, Bauditz Jürgen
, Stewart Paul M.
, Lochs Herbert
, Strasburger Christian J.
, Quinkler Marcus
Background: Non-alcoholic fatty liver disease (NAFLD) is recognized as common liver disorder that represents the hepatic manifestation of the metabolic syndrome including visceral obesity, type 2 diabetes, insulin resistance and hyperlipidemia. Non-alcoholic steatohepatitis (NASH) is the progressive form of liver injury with the risk for progressive fibrosis, cirrhosis and end-stage liver disease. The pathophysiology that leads to NAFLD and NASH is not well understood. We hypo...